The transfer membrane market is projected to reach USD 187.9
million by 2023 from USD 174.8 million in 2018, at a CAGR of 1.5% during the
forecast period. Transfer membrane is a microporous membrane that is used in
the detection, analysis of the proteins and nucleic acids. These are also used
to transferring proteins from gel matrices. These transfer membranes are used
in various blotting techniques such as northern, southern, western and protein
sequencing.
Download PDF Brochure @ https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=36975865
Factors such as increasing public and private funding for
life science research, the significantly high prevalence of target diseases
across the globe, and increasing R&D spending by pharmaceutical and
biotechnology companies are driving the growth of this market.
Market Segmentation
On the basis of types, the transfer membrane market
is classified into nylon transfer membrane, nitrocellulose transfer membrane,
and PVDF transfer membranes. In 2018, PVDF transfer membranes are expected to
command the major share of the transfer membrane market.. The PVDF transfer
membrane segment is expected to account for the largest share of the transfer
membrane market
On the basis of transfer method, the transfer
membrane market is segmented into tank electrotransfer, semi-dry
electrotransfer, dry electrotransfer, and other transfer methods (diffusion
blotting and vacuum blotting). The Dry electrotransfer segment is expected to
grow at the fastest CAGR during the forecast period.
Regional Analysis
North America is expected to account for the largest share
of the market in 2018, followed by Europe. The large share of North America can
primarily be attributed to presence of leading transfer membrane manufacturers
in the region, availability of government and private financial support for
life science research, and a high disease prevalence in the region.
Key Market Players:
The key players in the transfer membrane market include
Merck KGaA (US), Thermo Fisher Scientific (US), Bio-Rad Laboratories (US), GE
Healthcare (US), PerkinElmer (US), Pall Coporation (US), Advansta (US), GVS
(Italy), Santa Cruz Biotechnology (US), Abcam (UK), ATTO Corporation (Japan),
Carl Roth (Germany), Macherey-Nagel (Germany), Azure Biosystems (US), and Axiva
Sichem Biotech (India), among others.
Merck KGaA (US) held the leadership position in the
transfer membrane market. The company has a broad portfolio of transfer
membrane. Apart from its broad product portfolio, the company also has a strong
geographical presence and a wide customer base in emerging economies, including
Brazil, India, and China.
Objectives of the study are:
·
To define, describe, and forecast the market by
type, transfer method, application, end user, and region
·
To provide detailed information regarding the
major factors influencing market growth (drivers, restraints, and
opportunities) along with the current trends
·
To strategically analyze micromarkets with
respect to their individual growth trends, prospects, and contributions to the
total market
·
To analyze market opportunities for stakeholders
and provide details of the competitive landscape for key players
·
To forecast the revenue of the market segments
in North America, Europe, Asia Pacific, Latin America, and the Middle East and
Africa
·
To profile the key players and comprehensively
analyze their market shares and core competencies
·
To track and analyze competitive developments
such as acquisitions and expansions in the market